Sep 22
Current report
8-K
Regulation FD disclosure
ALZN · Alzamend Neuro, Inc. · Documents
$1.30
-0.01 (-0.76%)
At close · Nov 12
Return incl. dividend (before tax)
Going-concern doubt
— flagged Sep 10, 2026
Substantial doubt about the company's ability to continue as a going concern.
“These factors create substantial doubt about our ability to continue as a going concern for at least one year after the date that our condensed financial statements are issued.”View the 10-Q filed Sep 10, 2026
Market Cap
$6.27M
Shares
4.83M
Volume · Nov 12
23.72K
Avg daily vol (3M)
81.99K
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
The company's filings, earnings calls and investor events, most recent first. Search and read these filings from Claude or ChatGPT with the SEC filings MCP server →
2022
Sep 13
Aug 15
Current report
8-K
Regulation FD disclosure
Aug 5
Current report
8-K
Director or officer change, or executive pay
Jul 19
Jul 18
Current report
8-K
Delisting notice or listing transfer
Jun 28
Current report
8-K
Delisting notice or listing transfer
Jun 6
Current report
8-K
Regulation FD disclosure
Apr 20
Current report
8-K/A
Regulation FD disclosure, Other events
Apr 18
Current report
8-K
Regulation FD disclosure
Mar 15
2021
Dec 17
Current report
8-K
Regulation FD disclosure
Dec 13
Sep 30
Current report
8-K
Regulation FD disclosure
Sep 13
Aug 17
Current report
8-K
Regulation FD disclosure
Aug 4
Current report
8-K
Regulation FD disclosure
Jul 29
Jul 28
Current report
8-K
Regulation FD disclosure
Jul 23
Current report
8-K
Regulation FD disclosure
Jun 22
Current report
8-K
Events of Jun 17
Director or officer change, or executive pay
Jun 11
Registration statement
S-1/A
Registration statement
Jun 7
Registration statement
S-1/A
Registration statement
Jun 3
Registration statement
S-1/A
Registration statement
May 25
Registration statement
S-1/A
Registration statement
May 10
Registration statement
S-1
Registration statement
Showing 101–126 of 126 documents